https://www.cetsa.org/new-project daily 0.75 2019-06-07 https://www.cetsa.org/about daily 0.75 2019-06-14 https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/1559909823885-PMNADODF9MAXA9I8BJPF/par-nordlund.jpg About https://www.cetsa.org/team-stockholm daily 0.75 2022-05-06 https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/1c21fe3f-9ac9-444e-90a1-5d608f14048f/Jiawen.jpg Stockholm Jiawen Lyu Jiawen Lyu is a postdoctoral fellow in the CETSA team. Her previous works focused on the proteomic method development for studying ligand-protein interactome by mass spectrometry. Since 2021, she joined CESTA team in Karolinska Institute to study the cellular mechanism in cancer process and chemical therapy. https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/138286c5-5d53-4acc-bc6a-f9f92d29f735/Tamoghna.jpg Stockholm Tamoghna Mandal Tamoghna Mandal concluded his PhD research in 2019 from Ulm University, Germany. It was devolping and validating leukemic mouse models, transcriptomic plasticity and novel drug targeting sytems. He has been working with different aspects of Cancer Stem Cell biology since 2009. Presently perfoming Postdoc studies on immune checkpoint interactors using CETSA at Karolinska Institute. https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/c5e4e681-9beb-4df7-8572-082af883ae46/Anderson.jpg Stockholm Anderson Ramos Anderson Ramos completed his PhD in Immunology from the University of Sao Paulo in 2014 on the Immunomodulation of experimental autoimmune encephalomyelitis by the extract of the salivary glands of Aedes aegypti. He went on to do a Post doc in the Karolinksa Institutet on the Mechanism of insulin secretion in beta cells. He is currently a research fellow in the Nordlund lab at Karolinksa Institutet and working on using CETSA to study drug engagement and the different aspects of virus infection. https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/42ef5ff8-95bd-474d-b5d4-bfbeda88c7bb/Mindaugas.jpeg Stockholm Mindaugas Raitelaitis Mindaugas Raitelaitis is a PhD student in the lab. He is working on studying platinum compounds, their mechanisms of action and mechanism of resistance as chemotherapeutics. https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/1560503205338-87OTR5UY4CCMGSGZOUPG/20190614_084857.jpg Stockholm Sara Lööf Sara is a Project Leader in the CETSA team https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/a4704325-73cd-49ed-b4fc-b6f8a74efc62/Reto.jpeg Stockholm Reto Rufener Reto Rufener received his PhD in Molecular Life Sciences in 2020 from the University of Bern in Switzerland. Before he joined the CETSA group in Stockholm, he was a scientist in the field of molecular parasitology. Within the scope of his previous work, he investigated the mode of action of various drugs and was developing new chemotherapeutic treatment options against infectious diseases targeting the energy metabolism. In his current project, he employs CETSA to describe the mechanism of action of new anti-cancer drugs within the cellular context. Moreover, he is developing a particular drug screening assay based on the findings of previous CETSA studies. https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/1560503997384-GCZZYDY8IMIKDDDU2AWF/20190614_084912.jpg Stockholm Smaranda Bacanu Smaranda is a PhD student in the lab. She did her Masters in Neuroscience from Stockholm University 2015, Neurochemistry with molecular neurobiology. https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/1238db80-2587-47ff-991b-f9121e522388/Younis.jpeg Stockholm Mohd Younis Bhat Mohd Younis Bhat, completed his PhD in cancer biology from the Institute of Bioinformatics, Bangalore, India in 2021. He employed cutting-edge next-generation sequencing (NGS) and mass spectrometry platforms to study various cancer types such as oral squamous cell carcinoma and gastric adenocarcinoma. He is currently working with Dr. Pär Nordlund at Karolinska Institute, Sweden as a postdoc employing Cellular Thermal Shift Assay (CETSA) method to demonstrate ligand-protein interactions and cancer drug-target engagements in intact living cells. https://www.cetsa.org/publications daily 0.75 2022-05-12 https://www.cetsa.org/in-the-news daily 0.75 2022-05-12 https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/1559910738991-0OBN6OCQSVUXCYJ0SY1X/CETSA+flyer+final.png News https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/1563343186428-4FDG4MDJ14AI84Y7N26R/IMG_20190618_122347.jpg News https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/1563343483212-VHUJ8LBKRZAUYITXGMML/IMG_20190617_082819.jpg News https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/1563343462588-V227C30MRTZJ9RSUB77T/IMG_20190617_090732.jpg News https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/1563343452528-CNYXLGECJB9XCLMOTURK/IMG_20190617_090738.jpg News https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/1563343426354-4S68CLEWYM91O23S6VIK/IMG_20190617_093847.jpg News https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/1563343416049-VNA6F8RNOEWMF2KH9K7H/IMG_20190617_100405.jpg News https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/1563343382625-CGYAE8YVSU4YY0VB0U3O/IMG_20190617_111532.jpg News https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/1563343302399-G3QP1JI8MWQ3Z5A4UHK4/IMG_20190617_160757.jpg News https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/1563343345538-LNWMMSCTS715RSWAYNMO/IMG_20190617_150617.jpg News https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/1563343345761-8OGDF2Z4QTWS1R753FCN/IMG_20190617_140700.jpg News https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/1563343382403-HJRAZ1S856GUPS29LNSP/IMG_20190617_134332.jpg News https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/1563343386704-QKQSC6GUCLW3OZLU71L6/IMG-20190617-WA0002.jpg News https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/1563343261878-X9SCW1VMWH9TXYI1QCOE/IMG_20190617_192912.jpg News https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/1563343305804-G7QTW1ZXGGL1GNBY0AYE/IMG_20190617_185439.jpg News https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/1563343130345-SOX7G2XDYUV4AAJP5ITK/IMG-20190618-WA0015.jpg News https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/1563343236362-YUTU3TBEIG24XPZKLMC0/IMG_20190618_094607.jpg News https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/1563343166043-41Z1MTHMGG7YQVDNFZNM/IMG_20190618_112420.jpg News https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/1563343201670-QKGFCYQN3M0TT67UDQSZ/IMG_20190618_101636.jpg News https://www.cetsa.org/singapore daily 0.75 2022-05-12 https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/1559908936119-8U7VYI3DB0191ECPYPYA/Nayana_headshot.jpg Singapore Nayana Prabhu Nayana Prabhu obtained her Master’s degree in Biochemistry from Bangalore University, India. She spent three years working in the R&D sector in the Biotech industry in India. Soon after, she worked in the Animal Biotechnology laboratory at Temasek Lifeciences Laboratory, Singapore, studying H5N1 influenza viruses. Nayana then joined the Immunology Program at the National University of Singapore to undertake a PhD in Immunology. Her interest in drug discovery drew her to the CETSA approach to study target engagement in the laboratory of Prof. Par Nordlund at Nanyang Technological University. Nayana now leads the MS-CETSA team at IMCB. https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/4953c24b-2218-4a01-811c-73ddeb10e6f1/HaiVan.jpg Singapore - Make it stand out Le Hai Van Hai Van obtained her BSc with Biochemistry major from Vietnam National University in 2013. She then received her MSc studies in Life Science at Gachon University (Korea) in 2015 and graduated with a PhD degree from National University of Singapore in 2021. During her PhD study, she focused on how to apply Pt-based chemo-agents to stimulate anticancer immune responses using macrophage model. She then has joined Par Nordlund’s group as a research fellow at IMCB, A-STAR where she can broaden her knowledge and experience with MS-CETSA. https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/1559960949697-HGH1X1HFF0DEZMC0XF5Z/imcb_logo.png Singapore https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/09a1bc35-4ed5-4b9b-8cf4-3c88ac5339d2/b14e9726-dcbc-4b66-a64c-d7ae13a21c63.jpg Singapore Liang Ying Yu Ying Yu completed her undergraduate and postgraduate degrees in Molecular Biotechnology at the University of Applied Sciences Vienna and received her PhD from the Medical University of Vienna in 2016. Her work focussed on chemotherapy-induced immunogenic cell death as well as the effect of chemotherapy on the anti-tumour immune response in multiple myeloma patients. She then joined Par Nordlund’s group as a postdoctoral fellow at the Karolinska Institute Stockholm where she acquired her mass spectrometry (MS) skills and expertise in cellular thermal shift assay (CETSA). In 2020 she transferred to IMCB where she is currently working. https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/ef399322-94b0-4699-9e01-8ee21cfa210d/Khalidah.jpeg Singapore - Make it stand out Khalidah Khalid Khalidah completed her Honours degree in Life Science from the National University of Singapore in 2020. Before joining the CETSA team, she was involved in the study of methylated genes in colorectal cancer with the use of droplet digital PCR. For her honours project, she performed the isolation and characterization of bacteriophages targeting Pseudomonas aeruginosa. Currently, she is a research officer in the Nordlund group where she is involved in the study of drug-target engagement using the MS-CETSA approach. https://www.cetsa.org/home daily 1.0 2019-06-14 https://images.squarespace-cdn.com/content/v1/573a04372fe131630fd25157/1469729752911-UFETSG39XPIFRSHOM0XH/hero_pattern.png Home https://www.cetsa.org/contact daily 0.75 2025-09-23 https://www.cetsa.org/commercial-users daily 0.75 2025-09-23 https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/1abc95e3-7dc4-465f-9873-4bda139c9871/PELAGO+logo.jpg Commercial Users - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/5cfa4fd4cc3b6b0001382ce2/9a9fc0d1-8379-4a3e-ab13-b393b5e0e1a9/PELAGO+logo.jpeg Commercial Users